AGP Executive Report
Last update: an hour agoEbola Surge in DRC: DR Congo’s Bundibugyo Ebola outbreak has topped 2,000 cases with 754 deaths, and WHO warns the real toll may be 2–4 times higher as “unknown chains” drive spread and many deaths occur before people reach care. New Treatment Trial: A post-exposure trial (EBO-PEP) is enrolling people in Ituri to test Gilead’s obeldesivir after exposure, while WHO says there’s still no approved vaccine or treatment for this strain. Response Strain: MSF says the outbreak is accelerating faster than the medical response, and WHO officials flag gaps in contact tracing and data sharing. Cross-Border Pressure: The U.S. has imposed temporary travel restrictions for Americans in/returning from DRC, and a U.S. humanitarian worker in Congo has tested positive. Copper Stakes: Separately, DRC tax authorities sealed Kamoto Copper Company offices in a widening Glencore dispute over alleged unpaid taxes and transfer pricing—raising stakes for critical mineral supply.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
